Filіuk I. O., Kalbus O. I.

DAMAGE TO THE NERVOUS SYSTEM IN COVID-19

---

Show/Download

About the author:

Filіuk I. O., Kalbus O. I.

Heading:

LITERATURE REVIEWS

Type of article:

Scientific article

Annotation:

The COVID-19 pandemic is a pressing global issue and remains in the spotlight. The course of the disease can be varied, from asymptomatic, with manifestations of a mild respiratory infection to functional disorders of many body systems, namely the respiratory, cardiovascular, immune, as well as skin lesions and mental disorders (depression, anxiety, adaptation disorder). In most cases, the SARS-CoV-2 virus primarily affects the neurons of the olfactory bulb, which leads to impaired sense of smell and taste. Neurological manifestations after the disease can be very diverse, the most common symptom is headache, which can be different and different locations. On the part of the central nervous system, these are acute cerebrovascular disorders: ischemic and haemorrhagic strokes, meningoencephalitis, cranial nerve damage, peripheral nervous system damage, Guillain-Barre syndrome, musculoskeletal disorders, including rhabdomyolysis. In the medical literature, the term post-COVID syndrome is increasingly used to describe a set of complications of coronavirus infection that manifests itself in pathological conditions and has a long course, from 12 weeks and more, leading to the involvement of many body systems in the pathological process. To date, it is important to study in detail the markers of nervous system damage, primarily neurodegenerative diseases such as Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis and others after COVID-19 for early diagnosis and subsequent treatment to predict the quality of life in patients.

Tags:

Bibliography:

1. Carod Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Revista de Neurología. 2020;70(09):311.
2. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.
3. Siriken B, Güler A, editors. Coronavirus Disease (COVID-19). Lyon: Livre de Lyon; 2020. 66 p.
4. Hrycay EG, Bandiera SM. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. Cham: Springer International Publishing. 2015;851:1-61
5. Niaz K, Nisar MF. Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario. Emirate of Sharjah: Bentham Science Publishers; 2021. 449 p.
6. Markus HS, Brainin M. COVID-19 and stroke - A global World Stroke Organization perspective. International Journal of Stroke. 2020;15(4):361-4.
7. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine. 2020;382(26):2534-2543.
8. Villa C. Novel Biomarkers in Alzheimer’s Disease. Basel: MDPI; 2021. 442 p.
9. Fang J, Xie S, Li N, Jiang Z. Postoperative Complications Of Endoscopic Versus Microscopic Transsphenoidal Pituitary Surgery: A Metaanalysis. Journal of the College of Physicians and Surgeons Pakistan. 2018;28(7):554-9.
10. Hwang K, Yeom SH, Hwang SH. Complications of Nasal Bone Fractures. Journal of Craniofacial Surgery. 2017;28(3):803-5.
11. Singh PK, Khatri DK, Singh SB, Sriram A. An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy. Emirate of Sharjah: Bentham Science Publishers; 2022. 299 p.
12. Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104-3120.
13. Hsieh CY, Matias-Guiu JA, Porta-Etessam J, Sung SF, Nezu T, Allegri RF, et al. Consequences of the COVID-19 Pandemic on Care for Neurological Conditions. Frontiers in neurology. 2022;12:788912.
14. Berlit P, Bösel J, Gahn G, Isenmann S, Meuth SG, Nolte CH, et al. “Neurological manifestations of COVID-19” – a guideline of the German society of neurology. Neurol Res Pract 2020;2:51. DOI: 10.1186/s42466-020-00097-7.
15. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683-690.
16. Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. Journal of thrombosis and haemostasis. 2019;17(11):1989-94.
17. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. DOI: 10.1016/S0140-6736(20)30628-0.
18. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. New England Journal of Medicine. 2020;382(17):e38.
19. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. International Journal of Stroke. 2020;15(4):385-389.
20. Rajkumar C. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. The Lancet. 2013;396(10245):802-4.
21. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid - mechanisms, risk factors, and management. BMJ. 2021;374(1):n1648.
22. Arlen RK. New Research on Neurofilament Proteins. New York: Nova Science; 2007. 173 p.
23. Deisenhammer F, Teunissen CE, Tumani H. Cerebrospinal fluid in neurologic disorders. Amsterdam: Elsevier; 2017. 146 p.
24. Bechter K, Brown D, Najjar S. Editorial: Recent Advances in Psychiatry From Psycho-Neuro-Immunology Research: Autoimmune Encephalitis, Autoimmune Encephalopathy, and Mild Encephalitis. Frontiers in Psychiatry. 2019;10:169. DOI: https://doi.org/10.3389/ fpsyt.2019.00169.
25. Rawson T, Iosa M, Ricci F, Zisis Kozlakidis, Su L, Ropert C, et al. Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response. Volume II. Lausanne: Frontiers Media SA; 2023. 815 p.
26. Skripuletz T, Torkildsen O, Pul R, Sühs KW. New Cerebrospinal Fluid Research to Uncover Mechanisms Driving Neurological and Psychiatric Diseases. Lausanne: Frontiers Media SA; 2020. 169 p.

Publication of the article:

«Bulletin of problems biology and medicine», 2024 Issue 2, 173, 144-149 pages, index UDC 616.98:578.834COVID-19]-036.86-06:616.8-009

DOI:

10.29254/2077-4214-2024-2-173-144-149